Hope and Exploitation in Commercial Provision of Assisted Reproductive Technologies

Area of Science:

• Reproductive Medicine
• Medical Ethics

Background:

• Assisted reproductive technologies (ART) utilize add-on interventions to enhance standard in vitro fertilization (IVF) protocols.
• The commercialization of ART has led to a proliferation of add-ons, often marketed with equivocal supporting evidence.
• Patient hope for successful conception makes them vulnerable to these interventions.

Purpose of the Study:

• To analyze how the commercial provision of ART add-ons exploits patient hope.
• To propose ethical guidelines for the use of ART add-ons.

Main Methods:

• Ethical analysis of commercial ART practices.
• Review of existing patient safeguarding measures in ART.

Main Results:

• Current safeguards in ART neglect the exploitation of patient hope through add-on interventions.
• The marketing of add-ons in commercial ART preys on patient vulnerability and hope.

Conclusions:

• Commercial ART providers should offer add-ons exclusively free of charge.
• Add-on interventions should be provided only within the framework of a suitable research protocol to ensure ethical patient care.